If you think yesterday's news was big, wait until you hear what we have in store! Mediforum will be the first Korean pharmaceutical company to make history and list on NASDAQ. Here's to making more history together one step at a time!
For more info clic
Aducanumab, the latest drug approved by the FDA for the treatment of Alzheimer'sis estimated to cost $56,000 annually. According to the New York Times, "There’s little evidence that the drug, Aduhelm, slows the progression of dementia, but the Food and Dr
Brain One is a naturally derived supplement made from a combination of extracts to improve memory %26 concentration. Combining the natural compounds with four-year-aged Korean ginseng boosts the immune system, enhances platelet count, and increases blood
